IHU Infiny
@ihu-infiny.bsky.social
IHU Infiny - Institut des Maladies Inflammatoires Chroniques de l’Intestin (MICI)
📍Bâtiment IRIS - Hôpitaux de Brabois - CHRU Nancy, Vandoeuvre-lès-Nancy 54547
➡️ https://www.ihu-infiny.fr/
📍Bâtiment IRIS - Hôpitaux de Brabois - CHRU Nancy, Vandoeuvre-lès-Nancy 54547
➡️ https://www.ihu-infiny.fr/
🔬Recap from our #WorldIBDDay conference with Djésia Arnone & Benoit Chassaing – hosted by IHU Infiny & @afacrohnrch.bsky.social Crohn RCH
🧴❤️Microplastics, cardiovascular risk & IBD
Read more → www.ihu-infiny.fr/en/news/worl...
#WorldIBDDay #IBD #Research #TranslationalScience
🧴❤️Microplastics, cardiovascular risk & IBD
Read more → www.ihu-infiny.fr/en/news/worl...
#WorldIBDDay #IBD #Research #TranslationalScience
World IBD Day 2025: When research sheds light on hidden challenges – IHU INFINY
To mark World IBD Day, IHU Infiny and Afa Crohn RCH co-hosted a scientific conference highlighting two forward-looking research projects, supported by both
www.ihu-infiny.fr
May 19, 2025 at 1:33 PM
🔬Recap from our #WorldIBDDay conference with Djésia Arnone & Benoit Chassaing – hosted by IHU Infiny & @afacrohnrch.bsky.social Crohn RCH
🧴❤️Microplastics, cardiovascular risk & IBD
Read more → www.ihu-infiny.fr/en/news/worl...
#WorldIBDDay #IBD #Research #TranslationalScience
🧴❤️Microplastics, cardiovascular risk & IBD
Read more → www.ihu-infiny.fr/en/news/worl...
#WorldIBDDay #IBD #Research #TranslationalScience
📢 [Abstract submission] Join us on Oct 15, 2025 for a full day dedicated to scientific research in #IBD and #inflammation — basic, translational & clinical.
🌍 Connect with researchers & clinicians from across disciplines.
👉Submit : www.ihu-infiny.fr/actualites/f...
#IBD #CallForPapers #Futures2025
🌍 Connect with researchers & clinicians from across disciplines.
👉Submit : www.ihu-infiny.fr/actualites/f...
#IBD #CallForPapers #Futures2025
FUTURES 2025 - ABSTRACT SUBMISSION – IHU INFINY
The Infiny IBD Institute annual abstract submission is now open. We invite researchers, clinicians, and healthcare professionals to submit abstracts for
www.ihu-infiny.fr
April 22, 2025 at 8:12 AM
📢 [Abstract submission] Join us on Oct 15, 2025 for a full day dedicated to scientific research in #IBD and #inflammation — basic, translational & clinical.
🌍 Connect with researchers & clinicians from across disciplines.
👉Submit : www.ihu-infiny.fr/actualites/f...
#IBD #CallForPapers #Futures2025
🌍 Connect with researchers & clinicians from across disciplines.
👉Submit : www.ihu-infiny.fr/actualites/f...
#IBD #CallForPapers #Futures2025
[🔬 Conference – FR]💬 Better understand how environmental & systemic factors influence IBD (Inflammatory Bowel Disease).
📅 Fri, May 16 | 10:00–12:00
📍 IRIS Auditorium – Brabois Hospitals, Nancy
🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...
📅 Fri, May 16 | 10:00–12:00
📍 IRIS Auditorium – Brabois Hospitals, Nancy
🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...
Conférence INFINY - Recherche fondamentale – IHU INFINY
La recherche dans les MICI : mieux comprendre les dimensions environnementales et systémiques - Vendredi 16 mai 2025
www.ihu-infiny.fr
April 10, 2025 at 9:44 AM
[🔬 Conference – FR]💬 Better understand how environmental & systemic factors influence IBD (Inflammatory Bowel Disease).
📅 Fri, May 16 | 10:00–12:00
📍 IRIS Auditorium – Brabois Hospitals, Nancy
🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...
📅 Fri, May 16 | 10:00–12:00
📍 IRIS Auditorium – Brabois Hospitals, Nancy
🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...
Reposted by IHU Infiny
5 questions pour Comprendre le projet de recherche POL-MICI de soutenu par @afacrohnrch.bsky.social
@ihu-infiny.bsky.social
@ihu-infiny.bsky.social
[💡 POL-MICI : 5 questions à Marie Boudaud pour tout comprendre sur son… | IHU INFINY - Institut des maladies inflammatoires chroniques de l'intestin
[💡 POL-MICI : 5 questions à Marie Boudaud pour tout comprendre sur son projet de recherche]
À l’IHU Infiny, recherche fondamentale et clinique avancent main…
www.linkedin.com
March 13, 2025 at 3:11 PM
5 questions pour Comprendre le projet de recherche POL-MICI de soutenu par @afacrohnrch.bsky.social
@ihu-infiny.bsky.social
@ihu-infiny.bsky.social
🔬 #TuesdayReading
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
March 25, 2025 at 9:26 AM
🔬 #TuesdayReading
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes!
⬇️ 1/2
Reposted by IHU Infiny
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
March 11, 2025 at 9:40 AM
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
March 11, 2025 at 9:40 AM
🔬 #TuesdayReading
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Check out the March issue of @lancetgastrohep.bsky.social!
👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD)
⬇️
Reposted by IHU Infiny
The March issue of The Lancet Gastroenterology & Hepatology is out now at www.thelancet.com/gastrohep!
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#MedSky #GastroSky #LiverSky #IDSky #HepSky
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#MedSky #GastroSky #LiverSky #IDSky #HepSky
February 13, 2025 at 7:21 AM
The March issue of The Lancet Gastroenterology & Hepatology is out now at www.thelancet.com/gastrohep!
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#MedSky #GastroSky #LiverSky #IDSky #HepSky
Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more...
#MedSky #GastroSky #LiverSky #IDSky #HepSky
🔬 #TuesdayReading
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
February 11, 2025 at 12:24 PM
🔬 #TuesdayReading
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut!
1/3⬇️
🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru.
🚀 Stay tuned for exciting collaborations ahead.
🚀 Stay tuned for exciting collaborations ahead.
January 27, 2025 at 9:48 AM
🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru.
🚀 Stay tuned for exciting collaborations ahead.
🚀 Stay tuned for exciting collaborations ahead.
👋 Hello Bluesky!
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
January 24, 2025 at 4:05 PM
👋 Hello Bluesky!
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny
We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas!
➡️ Follow us on: linktr.ee/ihu_infiny